HAILEY ALFORD: Open Payments
NPI 1568062818 · MABANK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,467 in 82 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,467
Food & beverage: $1,467
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 20 | $296 |
| Lilly USA, LLC | 13 | $201 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 12 | $189 |
| AstraZeneca Pharmaceuticals LP | 4 | $147 |
| GlaxoSmithKline, LLC. | 6 | $146 |
| Dexcom, Inc. | 4 | $71 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $57 |
| ABBVIE INC. | 3 | $46 |
| Exact Sciences Corporation | 3 | $45 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
Products named: JARDIANCE, MOUNJARO, Ozempic, AIRSUPRA, Rybelsus, TRELEGY ELLIPTA, Dexcom G6 Transmitter, Kerendia.
Industry payments across TX — which companies pay providers there.
